NasdaqCM - Nasdaq Real Time Price USD
Lifeward Ltd. (LFWD)
1.2300
-0.0400
(-3.15%)
At close: May 30 at 4:00:01 PM EDT
1.2792
+0.05
+(4.00%)
Pre-Market: 8:00:29 AM EDT
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
25,663
25,663
13,854
5,511
5,966
Cost of Revenue
--
17,447
9,401
3,606
3,063
Gross Profit
8,216
8,216
4,453
1,905
2,903
Operating Expense
27,769
27,769
28,065
21,007
15,558
Operating Income
-19,553
-19,553
-23,612
-19,102
-12,655
Net Non Operating Interest Income Expense
515
515
1,334
-22
-25
Other Income Expense
-9,861
-9,861
133
22
38
Pretax Income
-28,899
-28,899
-22,145
-19,102
-12,642
Tax Provision
43
43
-12
467
94
Net Income Common Stockholders
-28,942
-28,942
-22,133
-19,569
-12,736
Diluted NI Available to Com Stockholders
-28,942
-28,942
-22,133
-19,569
-12,736
Basic EPS
-2.23
-3.33
-2.59
-2.20
-1.89
Diluted EPS
-2.23
-3.33
-2.59
-2.20
-1.89
Basic Average Shares
9,165.2870
8,691.2710
8,531.2940
8,911.2560
6,847.9500
Diluted Average Shares
8,644.3100
8,691.2710
8,531.2940
8,911.2560
6,847.9500
Total Operating Income as Reported
-29,347
-29,347
-23,612
-19,102
-12,655
Total Expenses
45,216
45,216
37,466
24,613
18,621
Net Income from Continuing & Discontinued Operation
--
-28,942
-22,133
-19,569
-12,736
Normalized Income
-21,349.0300
-21,349.0300
-22,265.9279
-19,585.9400
-12,765.2600
Interest Income
411
643
1,354
0
0
Interest Expense
--
--
--
0
0
Net Interest Income
515
515
1,334
-22
-25
EBIT
-17,904
-19,553
-23,612
-19,102
-12,655
EBITDA
-15,712
-15,712
-21,765
-18,900
-12,389
Reconciled Cost of Revenue
17,447
17,447
9,401
3,606
3,063
Reconciled Depreciation
3,841
3,841
1,847
202
266
Net Income from Continuing Operation Net Minority Interest
-28,942
-28,942
-22,133
-19,569
-12,736
Total Unusual Items Excluding Goodwill
-9,861
-9,861
133
22
38
Total Unusual Items
-9,861
-9,861
133
22
38
Normalized EBITDA
-5,851
-5,851
-21,898
-18,922
-12,427
Tax Rate for Calcs
0.0002
0.0002
0
0.0002
0.0002
Tax Effect of Unusual Items
-2,268.0300
-2,268.0300
0.0721
5.0600
8.7400
12/31/2021 - 9/12/2014
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
MYO Myomo, Inc.
2.9700
-2.94%
TIVC Tivic Health Systems, Inc.
4.1300
-1.67%
BJDX Bluejay Diagnostics, Inc.
1.5900
+1.92%
RBOT Vicarious Surgical Inc.
7.54
-2.71%
NUWE Nuwellis, Inc.
0.8600
-7.53%
NMTC NeuroOne Medical Technologies Corporation
0.6111
-5.14%
AIMD Ainos, Inc.
0.6750
-3.71%
SINT Sintx Technologies, Inc.
2.7100
-2.87%
IINN Inspira Technologies Oxy B.H.N. Ltd.
0.6101
+13.02%
DHAI DIH Holding US, Inc.
0.2293
-6.94%